Clinical features and outcomes in children with seronegative autoimmune encephalitis

Aim To characterize the presenting features and outcomes in children with seronegative autoimmune encephalitis, and to evaluate whether scores at nadir for the Modified Rankin Scale (mRS) and Clinical Assessment Scale for Autoimmune Encephalitis (CASE) or its paediatric‐specific modification (ped‐CA...

Full description

Saved in:
Bibliographic Details
Published in:Developmental medicine and child neurology Vol. 66; no. 10; pp. 1310 - 1318
Main Authors: Madani, Jihan, Yea, Carmen, Mahjoub, Areej, Brna, Paula, Jones, Kevin, Longoni, Giulia, Nouri, Maryam Nabavi, Rizk, Tamer, Stewart, Wendy A., Wilbur, Colin, Yeh, E. Ann
Format: Journal Article
Language:English
Published: England 01-10-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To characterize the presenting features and outcomes in children with seronegative autoimmune encephalitis, and to evaluate whether scores at nadir for the Modified Rankin Scale (mRS) and Clinical Assessment Scale for Autoimmune Encephalitis (CASE) or its paediatric‐specific modification (ped‐CASE) are predictive of outcomes. Method This observational study included children younger than 18 years of age with seronegative autoimmune encephalitis. Demographics and clinical data were collected. The mRS and CASE/ped‐CASE scores were used to evaluate disease severity. Descriptive statistics and logistic regression were used for data analysis and to evaluate associations between scale scores and outcomes. Results Sixty‐three children were included (39 [62%] females, median age 7 years, interquartile range [IQR] 4 years 1 months–11 years 6 months), with follow‐up available for 56 out of 63 patients (median follow‐up 12.2 months, IQR 13.4–17.8). The most frequent presenting neurological manifestation was encephalopathy (81%). Median CASE/ped‐CASE and mRS scores at nadir were 12.0 (IQR 7.0–17.0) and 1.0 (IQR 0–2.0) respectively. Thirty‐three patients (59%) had persistent neurological deficits at follow‐up. Both scoring systems suggested good functional recovery (mRS score ≤2, 95%; CASE/ped‐CASE score <5, 91%). CASE/ped‐CASE score was more likely than mRS to distinguish children with worse outcomes. Interpretation Children with seronegative autoimmune encephalitis are likely to have neurological deficits at follow‐up. CASE/ped‐CASE is more likely to distinguish children with worse outcomes than MRS. What this paper adds Encephalopathy was the most common reason for presentation in children with seronegative autoimmune encephalitis. Children with seronegative autoimmune encephalitis are likely to have neurological deficits at follow‐up. The Clinical Assessment Scale for Autoimmune Encephalitis or its paeditric version at nadir was better at distinguishing children with poor outcomes than the Modified Rankin Scale. What this paper adds Encephalopathy was the most common reason for presentation in children with seronegative autoimmune encephalitis. Children with seronegative autoimmune encephalitis are likely to have neurological deficits at follow‐up. The Clinical Assessment Scale for Autoimmune Encephalitis or its paeditric version at nadir was better at distinguishing children with poor outcomes than the Modified Rankin Scale. Presenting features and outcomes in children with seronegative autoimmune encephalitis. This original article is commented by Titulaer and Neuteboom on pages 1267–1268 of this issue.
Bibliography:This original article is commented by Titulaer and Neuteboom on pages
of this issue.
1267–1268
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0012-1622
1469-8749
1469-8749
DOI:10.1111/dmcn.15896